$67.39
At close: Apr 14 EDT
$67.37
-0.02-0.03%
Pre-Market: 6:06 PM EDT
Comments
Loading...
DexCom Analyst Ratings and Price Targets | NASDAQ:DXCM | Benzinga
DexCom Inc has a consensus price target of $120.19 based on the ratings of 26 analysts. The high is $500 issued by SVB Leerink on April 29, 2022. The low is $82 issued by Morgan Stanley on February 14, 2025. The 3 most-recent analyst ratings were released by Mizuho, Citigroup, and Canaccord Genuity on April 10, 2025, March 4, 2025, and February 14, 2025, respectively. With an average price target of $97.33 between Mizuho, Citigroup, and Canaccord Genuity, there's an implied 44.48% upside for DexCom Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Mizuho
Citigroup
Canaccord Genuity
Morgan Stanley
Redburn Atlantic
1calculated from analyst ratings
Analyst Ratings for DexCom
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/10/2025 | Buy Now | 26.17% | Mizuho | Anthony Petrone64% | → $85 | Initiates | → Outperform | Get Alert |
| 03/04/2025 | Buy Now | 54.37% | Citigroup | Joanne Wuensch75% | $101 → $104 | Maintains | Buy | Get Alert |
| 02/14/2025 | Buy Now | 52.89% | Canaccord Genuity | William Plovanic54% | $99 → $103 | Maintains | Buy | Get Alert |
| 02/14/2025 | Buy Now | 21.72% | Morgan Stanley | Patrick Wood50% | $75 → $82 | Maintains | Equal-Weight | Get Alert |
| 02/03/2025 | Buy Now | 70.7% | Redburn Atlantic | Issie Kirby24% | $85 → $115 | Upgrade | Neutral → Buy | Get Alert |
| 01/16/2025 | Buy Now | 54.37% | Baird | Jeff Johnson75% | $86 → $104 | Upgrade | Neutral → Outperform | Get Alert |
| 12/11/2024 | Buy Now | 35.07% | Citigroup | Joanne Wuensch75% | $85 → $91 | Maintains | Buy | Get Alert |
| 12/11/2024 | Buy Now | 39.53% | Wells Fargo | Larry Biegelsen67% | $90 → $94 | Maintains | Overweight | Get Alert |
| 12/09/2024 | Buy Now | 46.95% | Canaccord Genuity | William Plovanic54% | $89 → $99 | Maintains | Buy | Get Alert |
| 10/25/2024 | Buy Now | 27.65% | Bernstein | Lee Hambright63% | $82 → $86 | Maintains | Outperform | Get Alert |
| 10/25/2024 | Buy Now | 46.95% | Raymond James | Jayson Bedford69% | $115 → $99 | Maintains | Strong Buy | Get Alert |
| 10/25/2024 | Buy Now | 70.7% | RBC Capital | Shagun Singh54% | $120 → $115 | Maintains | Outperform | Get Alert |
| 10/25/2024 | Buy Now | 55.86% | Oppenheimer | Steven Lichtman62% | $115 → $105 | Maintains | Outperform | Get Alert |
| 10/25/2024 | Buy Now | 26.17% | JP Morgan | Robbie Marcus67% | $75 → $85 | Maintains | Neutral | Get Alert |
| 10/25/2024 | Buy Now | 29.14% | Leerink Partners | Mike Kratky64% | $90 → $87 | Maintains | Outperform | Get Alert |
| 10/25/2024 | Buy Now | 33.59% | Wells Fargo | Larry Biegelsen67% | $80 → $90 | Maintains | Overweight | Get Alert |
| 10/08/2024 | Buy Now | 78.12% | RBC Capital | Shagun Singh54% | $130 → $120 | Maintains | Outperform | Get Alert |
| 08/26/2024 | Buy Now | 33.59% | Piper Sandler | Matt O'Brien49% | $90 → $90 | Reiterates | Overweight → Overweight | Get Alert |
| 08/23/2024 | Buy Now | 48.43% | Stifel | Mathew Blackman60% | $90 → $100 | Maintains | Buy | Get Alert |
| 08/05/2024 | Buy Now | 21.72% | Baird | Jeff Johnson75% | $80 → $82 | Maintains | Neutral | Get Alert |
| 07/29/2024 | Buy Now | 67.73% | Barclays | Matt Miksic66% | $138 → $113 | Maintains | Equal-Weight | Get Alert |
| 07/26/2024 | Buy Now | 18.75% | Baird | Jeff Johnson75% | $161 → $80 | Downgrade | Outperform → Neutral | Get Alert |
| 07/26/2024 | Buy Now | 78.12% | BTIG | Marie Thibault62% | $156 → $120 | Maintains | Buy | Get Alert |
| 07/26/2024 | Buy Now | 11.33% | Morgan Stanley | Patrick Wood50% | $120 → $75 | Maintains | Equal-Weight | Get Alert |
| 07/26/2024 | Buy Now | 70.7% | Oppenheimer | Steven Lichtman62% | $150 → $115 | Maintains | Outperform | Get Alert |
| 07/26/2024 | Buy Now | 41.01% | UBS | Danielle Antalffy58% | $163 → $95 | Maintains | Buy | Get Alert |
| 07/26/2024 | Buy Now | 33.59% | Stifel | Mathew Blackman60% | $132 → $90 | Maintains | Buy | Get Alert |
| 07/26/2024 | Buy Now | 33.59% | Piper Sandler | Matt O'Brien49% | $150 → $90 | Maintains | Overweight | Get Alert |
| 07/26/2024 | Buy Now | 115.23% | RBC Capital | Shagun Singh54% | $165 → $145 | Maintains | Outperform | Get Alert |
| 07/26/2024 | Buy Now | 18.75% | Wells Fargo | Larry Biegelsen67% | $145 → $80 | Maintains | Overweight | Get Alert |
| 07/26/2024 | Buy Now | 32.11% | Canaccord Genuity | William Plovanic54% | $145 → $89 | Maintains | Buy | Get Alert |
| 07/26/2024 | Buy Now | 11.33% | JP Morgan | Robbie Marcus67% | $145 → $75 | Downgrade | Overweight → Neutral | Get Alert |
| 07/23/2024 | Buy Now | 115.23% | Canaccord Genuity | William Plovanic54% | $145 → $145 | Maintains | Buy | Get Alert |
| 07/15/2024 | Buy Now | 78.12% | Morgan Stanley | Patrick Wood50% | $132 → $120 | Maintains | Equal-Weight | Get Alert |
| 07/12/2024 | Buy Now | 95.93% | Stifel | Mathew Blackman60% | $145 → $132 | Maintains | Buy | Get Alert |
| 05/30/2024 | Buy Now | 92.96% | Redburn Atlantic | Issie Kirby24% | → $130 | Initiates | → Neutral | Get Alert |
| 04/26/2024 | Buy Now | 137.49% | Raymond James | Jayson Bedford69% | $151 → $160 | Maintains | Strong Buy | Get Alert |
| 04/26/2024 | Buy Now | 115.23% | Canaccord Genuity | William Plovanic54% | $144 → $145 | Maintains | Buy | Get Alert |
| 04/10/2024 | Buy Now | 141.95% | UBS | Danielle Antalffy58% | $153 → $163 | Maintains | Buy | Get Alert |
| 04/03/2024 | Buy Now | 138.98% | Citigroup | Joanne Wuensch75% | $148 → $161 | Maintains | Buy | Get Alert |
| 03/12/2024 | Buy Now | 144.92% | RBC Capital | Shagun Singh54% | → $165 | Initiates | → Outperform | Get Alert |
| 01/23/2024 | Buy Now | 124.13% | Raymond James | Jayson Bedford69% | $147 → $151 | Maintains | Strong Buy | Get Alert |
| 01/03/2024 | Buy Now | 118.2% | Raymond James | Jayson Bedford69% | $131 → $147 | Maintains | Strong Buy | Get Alert |
| 12/19/2023 | Buy Now | 122.65% | Piper Sandler | Matt O'Brien49% | $135 → $150 | Maintains | Overweight | Get Alert |
| 12/13/2023 | Buy Now | 101.87% | Wells Fargo | Larry Biegelsen67% | $110 → $136 | Maintains | Overweight | Get Alert |
| 12/04/2023 | Buy Now | 81.09% | Morgan Stanley | Patrick Wood50% | $101 → $122 | Maintains | Equal-Weight | Get Alert |
| 10/27/2023 | Buy Now | 49.92% | Morgan Stanley | Patrick Wood50% | $98 → $101 | Maintains | Equal-Weight | Get Alert |
| 10/17/2023 | Buy Now | 48.43% | JP Morgan | Michael Weinstein75% | $160 → $100 | Maintains | Overweight | Get Alert |
| 10/16/2023 | Buy Now | 63.28% | Leerink Partners | Mike Kratky64% | → $110 | Initiates | → Outperform | Get Alert |
| 10/10/2023 | Buy Now | 115.23% | Stifel | Mathew Blackman60% | $155 → $145 | Maintains | Buy | Get Alert |
| 09/29/2023 | Buy Now | 45.46% | Morgan Stanley | Patrick Wood50% | $131 → $98 | Maintains | Equal-Weight | Get Alert |
| 09/15/2023 | Buy Now | 94.45% | Raymond James | Jayson Bedford69% | $154 → $131 | Maintains | Strong Buy | Get Alert |
| 09/06/2023 | Buy Now | 104.84% | UBS | Danielle Antalffy58% | $175 → $138 | Maintains | Buy | Get Alert |
| 08/21/2023 | Buy Now | 92.96% | Baird | Jeff Johnson75% | $153 → $130 | Maintains | Outperform | Get Alert |
| 07/31/2023 | Buy Now | 104.84% | Barclays | Matt Miksic66% | $115 → $138 | Maintains | Equal-Weight | Get Alert |
| 07/28/2023 | Buy Now | 137.49% | Piper Sandler | Matt O'Brien49% | $150 → $160 | Maintains | Overweight | Get Alert |
| 07/28/2023 | Buy Now | 122.65% | Canaccord Genuity | Kyle Rose67% | $135 → $150 | Maintains | Buy | Get Alert |
| 07/28/2023 | Buy Now | 128.59% | Raymond James | Jayson Bedford69% | $140 → $154 | Maintains | Strong Buy | Get Alert |
| 07/28/2023 | Buy Now | 127.1% | Baird | Jeff Johnson75% | $145 → $153 | Maintains | Outperform | Get Alert |
| 07/11/2023 | Buy Now | 122.65% | Citigroup | Joanne Wuensch75% | $146 → $150 | Maintains | Buy | Get Alert |
| 06/26/2023 | Buy Now | 122.65% | BTIG | Marie Thibault62% | $134 → $150 | Maintains | Buy | Get Alert |
| 05/30/2023 | Buy Now | 94.45% | Morgan Stanley | Patrick Wood50% | → $131 | Assumes | → Equal-Weight | Get Alert |
| 05/01/2023 | Buy Now | 70.7% | Barclays | Matt Miksic66% | $110 → $115 | Maintains | Equal-Weight | Get Alert |
| 04/28/2023 | Buy Now | 107.81% | Stifel | Mathew Blackman60% | $130 → $140 | Maintains | Buy | Get Alert |
| 04/28/2023 | Buy Now | 98.9% | BTIG | Marie Thibault62% | $132 → $134 | Maintains | Buy | Get Alert |
| 04/28/2023 | Buy Now | 100.39% | Canaccord Genuity | Kyle Rose67% | $125 → $135 | Maintains | Buy | Get Alert |
| 04/28/2023 | Buy Now | 107.81% | Raymond James | Jayson Bedford69% | $138 → $140 | Maintains | Strong Buy | Get Alert |
| 04/17/2023 | Buy Now | 95.93% | BTIG | Marie Thibault62% | $126 → $132 | Maintains | Buy | Get Alert |
| 04/17/2023 | Buy Now | 104.84% | Raymond James | Jayson Bedford69% | $127 → $138 | Upgrade | Outperform → Strong Buy | Get Alert |
| 03/29/2023 | Buy Now | 110.78% | UBS | Danielle Antalffy58% | → $142 | Initiates | → Buy | Get Alert |
| 02/13/2023 | Buy Now | 63.28% | Barclays | Matt Miksic66% | $103 → $110 | Maintains | Equal-Weight | Get Alert |
| 02/10/2023 | Buy Now | 85.54% | Cowen & Co. | Joshua Jennings53% | $114 → $125 | Maintains | Outperform | Get Alert |
| 01/26/2023 | Buy Now | 79.6% | Wolfe Research | Mike Polark54% | → $121 | Initiates | → Outperform | Get Alert |
| 01/06/2023 | Buy Now | 94.45% | Morgan Stanley | Cecilia Furlong51% | $117 → $131 | Maintains | Equal-Weight | Get Alert |
| 12/12/2022 | Buy Now | 116.71% | Citigroup | Joanne Wuensch75% | $117 → $146 | Maintains | Buy | Get Alert |
| 10/28/2022 | Buy Now | 73.67% | Morgan Stanley | Cecilia Furlong51% | $107 → $117 | Maintains | Equal-Weight | Get Alert |
| 10/28/2022 | Buy Now | 89.99% | Wells Fargo | Larry Biegelsen67% | $102 → $128 | Maintains | Overweight | Get Alert |
| 10/28/2022 | Buy Now | 85.54% | Raymond James | Jayson Bedford69% | $101 → $125 | Maintains | Outperform | Get Alert |
| 10/18/2022 | Buy Now | 52.89% | Barclays | Matt Miksic66% | → $103 | Initiates | → Equal-Weight | Get Alert |
| 10/12/2022 | Buy Now | 85.54% | Jefferies | Matthew Taylor68% | → $125 | Initiates | → Buy | Get Alert |
| 10/11/2022 | Buy Now | 58.82% | Morgan Stanley | Cecilia Furlong51% | $83 → $107 | Maintains | Equal-Weight | Get Alert |
| 10/10/2022 | Buy Now | 63.28% | BTIG | Marie Thibault62% | $92 → $110 | Maintains | Buy | Get Alert |
| 10/07/2022 | Buy Now | 78.12% | Stifel | Mathew Blackman60% | $112 → $120 | Maintains | Buy | Get Alert |
| 10/07/2022 | Buy Now | 78.12% | Piper Sandler | Matt O'Brien49% | $110 → $120 | Maintains | Overweight | Get Alert |
| 08/01/2022 | Buy Now | 49.92% | Raymond James | Jayson Bedford69% | $122 → $101 | Maintains | Outperform | Get Alert |
| 07/29/2022 | Buy Now | 23.2% | Morgan Stanley | Cecilia Furlong51% | $91 → $83 | Maintains | Equal-Weight | Get Alert |
| 07/29/2022 | Buy Now | 63.28% | Piper Sandler | Matt O'Brien49% | $120 → $110 | Maintains | Overweight | Get Alert |
| 07/15/2022 | Buy Now | 55.86% | Bernstein | Lee Hambright63% | → $105 | Initiates | → Outperform | Get Alert |
| 06/24/2022 | Buy Now | 55.86% | BTIG | Marie Thibault62% | $135 → $105 | Maintains | Buy | Get Alert |
| 06/15/2022 | Buy Now | 35.07% | Morgan Stanley | David Lewis71% | $90.75 → $91 | Maintains | Equal-Weight | Get Alert |
| 06/13/2022 | Buy Now | 34.7% | Morgan Stanley | David Lewis71% | $363 → $90.75 | Maintains | Equal-Weight | Get Alert |
| 06/07/2022 | Buy Now | 438.81% | Morgan Stanley | David Lewis71% | $123 → $90.75 | Maintains | Equal-Weight | Get Alert |
| 05/17/2022 | Buy Now | 679.28% | Citigroup | Joanne Wuensch75% | $157.5 → $131.25 | Maintains | Buy | Get Alert |
| 04/29/2022 | Buy Now | 621.39% | Raymond James | Jayson Bedford69% | $134.5 → $121.5 | Maintains | Outperform | Get Alert |
| 04/29/2022 | Buy Now | 630.29% | Morgan Stanley | David Lewis71% | $128.5 → $123 | Maintains | Equal-Weight | Get Alert |
| 04/29/2022 | Buy Now | 612.48% | Piper Sandler | Matt O'Brien49% | $181.25 → $120 | Maintains | Overweight | Get Alert |
| 04/29/2022 | Buy Now | 642.17% | SVB Leerink | Danielle Antalffy58% | $141.25 → $125 | Maintains | Outperform | Get Alert |
FAQ
What is the target price for DexCom (DXCM) stock?
The latest price target for DexCom (NASDAQ:DXCM) was reported by Mizuho on April 10, 2025. The analyst firm set a price target for $85.00 expecting DXCM to rise to within 12 months (a possible 26.17% upside). 38 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for DexCom (DXCM)?
The latest analyst rating for DexCom (NASDAQ:DXCM) was provided by Mizuho, and DexCom initiated their outperform rating.
When was the last upgrade for DexCom (DXCM)?
The last upgrade for DexCom Inc happened on February 3, 2025 when Redburn Atlantic raised their price target to $115. Redburn Atlantic previously had a neutral for DexCom Inc.
When was the last downgrade for DexCom (DXCM)?
The last downgrade for DexCom Inc happened on July 26, 2024 when Baird changed their price target from $161 to $80 for DexCom Inc.
When is the next analyst rating going to be posted or updated for DexCom (DXCM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of DexCom, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for DexCom was filed on April 10, 2025 so you should expect the next rating to be made available sometime around April 10, 2026.
Is the Analyst Rating DexCom (DXCM) correct?
While ratings are subjective and will change, the latest DexCom (DXCM) rating was a initiated with a price target of $0.00 to $85.00. The current price DexCom (DXCM) is trading at is $67.37, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.